Начало › Рак на панкреаса › Ню Йорк › New York City
Клинични проучвания за Рак на панкреаса в New York City, NY
60 проучвания за Рак на панкреаса търсят участници в обекти в и около New York City (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- Research Site, New York
- Research Site, New York
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Набиране на участнициФаза 3
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Набиране на участници
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набиране на участнициФаза 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- и още 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 2
- Memorial Sloan Kettering Hospital, New York
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Набиране на участнициФаза 3
- Columbia University Irving Medical Center, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Набиране на участнициФаза 1
- Columbia University Irving Medical Center, New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Набиране на участнициНаблюдателно проучване
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Набиране на участнициФаза 2/3
- Icahn School of Medicine at Mount Sinai, New York
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Набиране на участнициФаза 3
- Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- и още 1
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Набиране на участнициФаза 3
- Investigative Site US031, New York
- Investigative Site US003, New York
- Investigative Site US041, New York
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Набиране на участнициФаза 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Набиране на участнициФаза 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Набиране на участнициФаза 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Набиране на участнициФаза 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Набиране на участнициФаза 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Набиране на участнициНаблюдателно проучване
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Набиране на участнициФаза 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Набиране на участнициФаза 2
- NYU-Manhattan, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Набиране на участнициФаза 1
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Набиране на участници
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Набиране на участнициФаза 1/2
- Mount Sinai Hospital, New York
- NYP/Weill Cornell Medical Center, New York
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Набиране на участници
- NYU Langone Health, New York
- Lenox hill Hospital, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Набиране на участнициФаза 1
- New York Cancer & Blood Specialists, New York
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Набиране на участнициФаза 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- и още 2
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan - Kettering Cancer Center, New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities), New York
- Weill Cornell Medical Center, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- Investigative Site #103, New York
- Investigative Site #106, New York
Pancreatic Cancer Early Detection Consortium
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Irving Medical Center, New York
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Набиране на участнициФаза 2
- NYU Langone Health Perlmutter Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
Набиране на участнициНаблюдателно проучване
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Набиране на участнициФаза 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набиране на участнициФаза 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Набиране на участнициФаза 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Набиране на участнициФаза 1
- Columbia University Irving Medical Center, New York
Pancreatic Cancer Genetics
Набиране на участнициНаблюдателно проучване
- Columbia University Medical Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Icahn School of Medicine at Mt. Sinai, New York
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Columbia University Medical Center, New York
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
Набиране на участнициФаза 1/2
- Columbia University Irving Medical Center, New York
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Набиране на участнициФаза 2
- Ohio State University-Telemedicine, New York
Pancreas Registry and High Risk Registry
Набиране на участнициНаблюдателно проучване
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Cancer Center, New York
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Набиране на участнициНаблюдателно проучване
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Multiparametric Ultrasound Imaging Methods
Набиране на участнициЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Набиране на участнициФаза 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
Набиране на участнициФаза 1
- Tisch Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
Набиране на участнициФаза 3
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Exelixis Clinical Site #5, New York
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Набиране на участнициНаблюдателно проучване
- Icahn School of Medicine at Mount Sinai, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Набиране на участнициФаза 1
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
Набиране на участнициФаза 2
- Columbia University Medical Center, New York
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Набиране на участнициФаза 2/3
- Columbia University Medical Center, New York
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Набиране на участнициФаза 2
- Icahn School of Medicine at Mount Sinai, New York
Проучвания за Рак на панкреаса в други градове
- Houston, TX61 проучвания
- Boston, MA43 проучвания
- Nashville, TN39 проучвания
- Los Angeles, CA35 проучвания
- St. Louis, MO33 проучвания
- Arlington, VA33 проучвания
- Baltimore, MD31 проучвания
- San Antonio, TX31 проучвания
- Philadelphia, PA26 проучвания
- Tampa, FL26 проучвания
- Durham, NC24 проучвания
- San Diego, CA24 проучвания
Други проучвания в New York City
- Рак на гърдата136 проучвания
- Рак на белия дроб с недребноклетъчен тип121 проучвания
- Рак (всички видове)109 проучвания
- Рак на простатата103 проучвания
- Метастатичен рак93 проучвания
- Колоректален рак78 проучвания
- Рак на яйчниците69 проучвания
- Рак на белия дроб60 проучвания
- Множествен миелом60 проучвания
- Ендометриален рак52 проучвания
- Остра миелоидна левкемия51 проучвания
- Сърдечна недостатъчност51 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.